New York University School of Medicine, New York, New York.
University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
Arthritis Care Res (Hoboken). 2023 May;75(5):1007-1016. doi: 10.1002/acr.24960. Epub 2023 Jan 11.
Using the Manhattan Lupus Surveillance Program, a multiracial/ethnic population-based registry, we aimed to compare 3 commonly used classification criteria for systemic lupus erythematosus (SLE) to identify unique cases and determine the incidence and prevalence of SLE using the EULAR/American College of Rheumatology (ACR) criteria.
SLE cases were defined as fulfilling the 1997 ACR, the Systemic Lupus International Collaborating Clinics (SLICC), or the EULAR/ACR classification criteria. We quantified the number of cases uniquely associated with each and the number fulfilling all 3 criteria. Prevalence and incidence using the EULAR/ACR classification criteria and associated 95% confidence intervals (95% CIs) were calculated.
A total of 1,497 cases fulfilled at least 1 of the 3 classification criteria, with 1,008 (67.3%) meeting all 3 classifications, 138 (9.2%) fulfilling only the SLICC criteria, 35 (2.3%) fulfilling only the 1997 ACR criteria, and 34 (2.3%) uniquely fulfilling the EULAR/ACR criteria. Patients solely satisfying the EULAR/ACR criteria had <4 manifestations. The majority classified only by the 1997 ACR criteria did not meet any of the defined immunologic criteria. Patients fulfilling only the SLICC criteria did so based on the presence of features unique to this system. Using the EULAR/ACR classification criteria, age-adjusted overall prevalence and incidence rates of SLE in Manhattan were 59.6 (95% CI 55.9-63.4) and 4.9 (95% CI 4.3-5.5) per 100,000 population, with age-adjusted prevalence and incidence rates highest among non-Hispanic Black female patients.
Applying the 3 commonly used classification criteria to a population-based registry identified patients with SLE fulfilling only 1 validated definition. The most recently developed EULAR/ACR classification criteria revealed prevalence and incidence estimates similar to those previously established for the ACR and SLICC classification schemes.
利用曼哈顿狼疮监测计划(一个多种族/族裔的基于人群的登记处),我们旨在比较三种常用于系统性红斑狼疮(SLE)的分类标准,以确定独特的病例,并使用 EULAR/美国风湿病学会(ACR)标准确定 SLE 的发病率和患病率。
SLE 病例被定义为符合 1997 年 ACR、系统性红斑狼疮国际合作诊所(SLICC)或 EULAR/ACR 分类标准。我们量化了每种标准独特关联的病例数量以及同时符合三种标准的病例数量。使用 EULAR/ACR 分类标准和相关的 95%置信区间(95%CI)计算了发病率和患病率。
共有 1497 例至少符合三种分类标准中的一种,其中 1008 例(67.3%)符合所有三种分类标准,138 例(9.2%)仅符合 SLICC 标准,35 例(2.3%)仅符合 1997 年 ACR 标准,34 例(2.3%)仅符合 EULAR/ACR 标准。仅符合 EULAR/ACR 标准的患者有<4 种表现。大多数仅通过 1997 年 ACR 标准分类的患者未满足任何定义的免疫学标准。仅符合 SLICC 标准的患者是基于该系统特有的特征。使用 EULAR/ACR 分类标准,曼哈顿的 SLE 年龄调整总体患病率和发病率分别为 59.6(95%CI 55.9-63.4)和 4.9(95%CI 4.3-5.5)/100,000 人,其中非西班牙裔黑人女性患者的年龄调整患病率和发病率最高。
将三种常用的分类标准应用于人群登记处,确定了仅符合一种经过验证的定义的 SLE 患者。最新开发的 EULAR/ACR 分类标准显示的患病率和发病率估计与之前为 ACR 和 SLICC 分类方案确定的估计值相似。